[1]Pantopoulos K, Porwal SK, Tartakoff A, et al.Mechanisms of Manmalion Iron Homeostasis[J].Biochemistry, 2012, 51(29):5705-5724
[2]Munoz M, Garcia-Erce JA, Remacha AF.Disorders of iron metabolismPart 1: Molecular basis of iron homoeostasis.[J].J Clin Pathol, 2011, 64(4):281-286
[3]Wang J, Pantopoulos K.Regulation of cellular iron metabolism[J].Biochem. J., 2011, 434(3):365-381
[4]Waldvogel-Abramowski S, Waeber G, Gassner C, et al.Physiology of Iron Metabolism. [J].Transfus. Med. Hemother, 2014, 41(3):213-221
[5]Hooda J, Shah A, Zhang L.Heme,an Essential Nutrient from Dietary Proteins,Critically Impacts Diverse Physiological and Pathological Processes[J].Nutrients, 2014, 6(3):1080-1102
[6]Shayeghi M, Latunde-Dada GO, Oakhill JS, et al.Identifification of an intestinal heme transporter[J].Cell, 2005, 122(5):789-801
[7]Qiu A, Jansen M, Sakaris A,et al..Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption[J].Cell, 2006, 127(5):917-928
[8]Gulec S, Anderson GJ, Collins JF.Mechanistic and regulatory aspects of intestinal iron absorption[J].Am. J. Physiol. Gastroint. Liver Physiol, 2014, 307(4):G397-409
[9]Luo X, Hill M, Johnson A,et al. .Modulation of Dcytb (Cybrd 1) expression and function by iron, dehydroascorbate and Hif-2α in cultured cells.[J].Biochim Biophys Acta., 2014, 1840(1):106-112
[10]Chen H, Attieh Z, Su T,et al. .Hephaestin is a ferroxidase that maintains partial activity in sex-linked anemia mice.[J].Blood, 2004, 103(10):3933-3939
[11]Kohgo Y, Ikuta K, Ohtake T,et al..Body iron metabolism and pathophysiology of iron overload.[J].Int. J. Hematol., 2008, 88(1):7-15
[12]De Domenico I, McVey Ward D, Kaplan J..Regulation of iron acquisition and storage: consequences for iron-linked disorders.[J].Nat Rev Mol Cell Biol., 2008, 9(1):72-81
[13]Ohgami RS, Campagna DR, McDonald A,et al..The Steap proteins are metalloreductases[J].Blood, 2006, 108(4):1388-1394
[14]Khalil S, Holy M, Grado S, et al..A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2.[J].Blood Adv, 2017, 1(15):1181-1194
[15]Troadec MB, Warner D, Wallace J,et al.Targeted deletion of the mouse Mitoferrin1 gene: from anemia to protoporphyria.[J].Blood, 2011, 117(20):5494-5502
[16]Chen W, Dailey HA, Paw BH.Ferrochelatase forms an oligomeric complex with mitoferrin-1 and Abcb10 for erythroid heme biosynthesis.[J].Blood, 2010, 116(4):628-630
[17]Qiao B, Sugianto P, Fung E, et al.Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.[J].Cell Metab, 2012, 15(6):918-924
[18]Enns CA, Ahmed R, Wang J, et al.. , 8, e60534.[J].PLoS ONE , 2013, 8(4):e60534-e60534
[19]Gao J, Chen J, Kramer M,et al..Interaction of the Hereditary Hemochromatosis Protein HFE with Transferrin Receptor 2 Is Required for Transferrin-Induced Hepcidin Expression.[J].Cell Metab, 2009, 9(3):217-227
[20]Wrighting DM, Andrews NC.Interleukin-6 induces hepcidin expression through STAT3.[J].Blood, 2006, 108(6):3204-3209
[21]Camaschella C.Iron defificiency[J].Blood, 2019, 133(1):30-39
[22]Lopez A, Cacoub P, Macdougall IC, et al..Iron defificiency anaemia[J].Lancet, 2016, 387(10021):907-916
[23]Skikne BS, Punnonen K, Caldron PH, et al..Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index.[J].Am J Hematol, 2011, 86(11):923-927
[24]Heeney MM, Guo D, De Falco L, et al.Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency.[J].Blood, 2018, 132(4):448-452
[25]Ganz T. 2015; (4): 577–578.[J].Clin Chem, 2015, 61(4):577-578
[26]El Gendy FM, El-Hawy MA, Shehata AMF, et al.Erythroferrone and iron status parameters levels in pediatric patients with iron deficiency anemia.[J].Eur J Haematol , 2018, 100(4):356-360
[27]Cappellini MD, Comin-Colet J, de Francisco A,et al.Iron defificiency across chronic inflflammatory conditions: International expert opinion on defifinition, diagnosis, and management[J].Am J Hematol , 2017, 92(10):1068-1078
[28]Achebe MM, Gafter-Gvili A.How I treat anemia in pregnancy: iron, cobalamin, and folate[J].Blood, 2017, 129(8):940-949
[29]Breymann C, Milman N, Mezzacasa A,et al. . 2017; 45: 443–53.[J].J Perinat Med , 2017, 45(4):443-453
[30]Lewis GD, Malhotra R, Hernandez AF, et al..Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron defificiency: the IRONOUT HF randomized clinical trial[J].JAMA, 2017, 317(19):1958-1966
[31]Qunibi WY, Martinez C, Smith M.et al..A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron defificiency anaemia of non-dialysis-dependent chronic kidney disease patients[J].Nephrol Dial Transplant , 2011, 26(5):1599-1607
[32]Pfeffer MA, Burdmann EA, Chen CY et al.A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease[J].N Engl J Med , 2009, 361(21):2019-2032
[33]Macdougall IC, White C, Anker SD,et al..Intravenous iron in patients undergoing maintenance hemodialysis. [J].N Engl J Med , 2019, 380(5):447-458
[34]Salim SA, Cheungpasitporn W, Elmaraezy A,et al..Infectious complications and mortality associated with the use of IV iron therapy: a systematic review and meta-analysis[J].Int Urol Nephrol , 2019, 51(10):1855-1865
[35]Lebrun F, Klastersky J, Levacq D, et al..Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies.[J].Support Care Cancer, 2017, 25(7):2313-2319
[36]Keeler BD, Simpson JA, Ng O,et al..Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer[J].Br J Surg, 2017, 104(3):214-221
